Axis Bank Moody’s Assigns Baa3 Rating with Stable Outlook to Senior Notes

Axis Bank Limited announced that Moody’s Investors Service has assigned a Baa3 rating with a stable outlook to the Senior Notes issued by its Gift City Branch under the Global Medium Term Note (GMTN) programme. The specific notes total USD 300,000,000 with a fixed rate of 5.348% and a maturity date of June 30, 2031. This action reflects Moody’s assessment of the bank’s credit risk.

Rating Action on Axis Bank Senior Notes

Axis Bank Limited has received a new credit rating from Moody’s Investors Service. In a communication dated June 24, 2026, Moody’s announced the assignment of a Baa3 rating with a stable outlook. This rating applies to the Senior Notes issued by Axis Bank’s Gift City Branch as part of its existing Global Medium Term Notes (“GMTN”) programme.

Details of the Rated Obligation

The specific obligation that has been rated is the USD 300,000,000 Fixed Rate Senior Unsecured Notes. These notes carry a coupon rate of 5.348% and are due on June 30, 2031. The ISIN for these notes is XS3423944779. Moody’s decision is based on the Pricing Supplement dated June 23, 2026, which was understood to be in substantially final form.

Programme and Issuance Context

These Senior Notes were issued under the Axis Bank Limited’s Global Medium Term Note Programme, under which the bank has the capacity to issue up to USD 5,000,000,000. The issuance is specifically from the bank’s GIFT City International Banking Unit (IBU).

Moody’s Rating Rationale and Disclaimer

Moody’s stated that the Baa3 rating with a stable outlook reflects their current opinion of the relative future credit risk associated with the notes. The rating rationale letter has been provided separately. Moody’s also clarified that credit ratings are not recommendations to buy, sell, or hold securities and are subject to potential suspension, reduction, or withdrawal. Investors are advised to analyze the significance of each rating independently.

Confidentiality Notice

The letter from Moody’s contained a strict confidentiality notice, restricting disclosure to legal counsel, authorized agents with non-disclosure agreements, or as required by law, unless prior written consent from Moody’s is obtained.

Source: BSE

Previous Article

Biocon Duopharma Biotech Secures MYR 225 Million in Insulin Tenders